The acquisition of Aetna by CVS Health, which came at a price tag of $69 billion and brought together the nation’s third-largest health insurance provider with one of the biggest pharmacy retailers and pharmacy benefit managers (PBMs), is at risk as the transaction is still under review by a court.
Teva Pharmaceuticals is pulling six bulk lots of its angiotensin II receptor blocker losartan from the market after testing revealed dangerously high levels of N-Nitroso-N-methyl-4-aminobutyric acid, a probable human carcinogen, in the drugs.
Combining AI with advances in acoustic engineering, Australian researchers have developed an algorithm that can help diagnose common pediatric respiratory conditions such as asthma, croup and pneumonia.
Alzheimer’s disease, a progressive brain disorder with no known cure that affects more than 5.5 million Americans, may finally be preventable. That’s if a vaccine developed by researchers at the University of New Mexico currently being tested turns out to be viable, reports local news outlet KRQE.
The American College of Cardiology is partnering with Chicago-based company Veradigm to assemble the largest-ever ambulatory chronic disease network in the U.S., comprising more than 250,000 clinicians and 100 million patients.
A collaboration between cardiologists and dentists at the Karolinska Institutet in Sweden has linked undetected glucose disorders like diabetes to an increased risk of myocardial infarction and periodontitis, a severe gum disease.
Microsoft is launching a regional hub for AI, Internet of Things and data science in Louisville, Kentucky, according to Mayor Greg Fischer, with a focus on collaborating with partners in healthcare and manufacturing.